| Ranbaxy recalls drug in US | 20-NOV-09 |
|
| India’s leading drug maker Ranbaxy has initiated a voluntary recall of 4,348 cartons of its skin infection drug Sotret (isotretinoin) in the United States. The entire lot pertains to a single batch of tablets which were found to be ‘out of specification’. |
|
|
|
| European NGOs back Indian generic drugs | 19-NOV-09 |
|
| Renowned European NGOs, including Oxfam and Medecins Sans Frontieres, have thrown their weight behind the Indian generic drug industry, whose products have been seized by authorities in Europe alleging violation of patents. |
|
|
|
|
|
|
| Wockhardt, Sun get US okay for generic drug | 19-NOV-09 |
|
| Indian drug companies Wockhardt and Sun Pharmaceutical Industries have received final approval from the United States Food and Drug Administration (USFDA) to market generic versions of Nicardipine, the hypertension drug. |
|
|
|
| Food laced with drugs: Kasab | 19-NOV-09 |
|
| Pakistani gunman Ajmal Kasab has complained to the 26/11 terror trial court that food given to him in jail is laced with tranquilisers, but medical experts say there is no truth in his allegations, special public prosecutor Ujjwal Nikam said here today. |
|
|
|
|
|
|
| Wockhardt gets FDA nod for Nicardipine injections | 18-NOV-09 |
|
| Drug firm Wockhardt today said it has received the final approval from the US Food and Drug Administration (FDA) for marketing Nicardipine HCI injections in 25mg/10 ml strength, used in the treatment of hypertension. |
|
|
|
| Protectionism by another name | 18-NOV-09 |
|
| The India-European Union Joint Customs Cooperation Committee has met in New Delhi and failed to resolve the issue over Indian generic drugs being seized when they are in transit through European ports. This may be ascribed to technical reasons, but it has ramifications for international trade and, equally importantly, for public health. The stand-off comes barely weeks after the assurance by EU’s trade commissioner, Catherine Ashton, that the EU was committed to finding a solution that works for India. The EU’s plea that such seizures are made on suspicion of either violation of intellectual property rights (IPRs), notably patent laws, or of the consignments being of counterfeit drugs, holds no water because there is no evidence to back such a position. All the consignments detained so far have eventually been found to be of genuine, off-patent generic drugs on their way to countries where these are not patented. |
|
|
|
|
|
|
| No cure in sight for India-EU drug seizure controversy | 14-NOV-09 |
|
| India and the European Union (EU) have begun discussions to resolve the ongoing dispute over the seizure of Indian generic drugs consignments in transit at European ports. Lutz Guellner, spokesperson for the European Trade Commissioner, told Business Standard that a meeting of the EU-India Joint Customs Cooperation Committee held in New Delhi on Thursday proved “constructive” with an “open discussion of the issues” taking place. |
|
|
|
|
|
|
|
|
|
| Venus Remedies bags patent for Potentox in SA | 12-NOV-09 |
|
| Venus Remedies has bagged patent for Potentox drug from South African patent controller. This is the company’s third product patent in South Africa this year. Companies Intellectual Property Registration Office, South Africa, has granted the company patent of two more drugs – Sulbactomax and Tobracef. |
|
|
|
| Cipla launches generic drug to treat H1N1 | 12-NOV-09 |
|
| Indian drug major Cipla has launched generic versions of anti-flu drugs oseltamivir and zanamivir in the local market to treat the H1N1 influenza, which is spreading across the globe and in India. |
|
|
|
|
|
|
Content Guide
